Cooper Companies (The) (COO)

Nasdaq Health Care Health Care Supplies S&P 500
$62.36
-1.15 (-1.81%)
Close of Nov 06, 2026 · end-of-day data
Source: Cooper Companies (The)'s 10-K / 10-Q XBRL data on SEC EDGAR · fetched Nov 04, 2026

Revenue, net income & free cash flow

Income statement

fiscal years · USD
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue$1.97B$2.14B$2.53B$2.65B$2.43B$2.92B$3.31B$3.59B$3.90B$4.09B
Cost of revenue$793.70M$773.20M$900.50M$896.60M$896.10M$966.70M$1.17B$1.24B$1.30B$1.41B
Gross profit$1.17B$1.37B$1.63B$1.76B$1.53B$1.96B$2.14B$2.36B$2.60B$2.68B
Research & development$65.40M$69.20M$84.80M$86.70M$93.30M$92.70M$110.30M$137.40M$155.10M$172.20M
Selling, general & admin$722.80M$799.10M$973.30M$996.20M$992.50M$1.21B$1.34B$1.50B$1.53B$1.63B
Operating income$324.10M$429.10M$403.10M$546.70M$311.80M$505.80M$507.60M$533.10M$705.70M$682.90M
Interest expense$26.20M$33.40M$82.70M$68.00M$36.80M$23.10M$57.30M$105.30M$114.30M$100.00M
Pre-tax income$295.60M$394.00M$331.90M$477.40M$266.50M$491.50M$475.30M$412.90M$582.30M$566.50M
Income tax$20.70M$21.10M$192.00M$10.70M$28.10M-$2.45B$89.50M$118.70M$190.00M$191.60M
Net income$273.90M$372.90M$139.90M$466.70M$238.40M$2.94B$385.80M$294.20M$392.30M$374.90M
EBITDA$522.40M$617.50M$678.20M$827.50M$461.70M$815.10M$853.70M$900.80M$1.08B$1.06B
EPS (basic)$5.65$7.63$2.85$9.44$4.85$59.80$1.95$1.49$1.97$1.88
EPS (diluted)$5.59$7.52$2.81$9.33$4.81$59.16$1.94$1.48$1.96$1.87
Diluted shares49.00M49.60M49.70M50.00M49.60M49.80M198.80M199.30M200.40M200.00M
Gross margin59.6%63.9%64.4%66.2%63.1%66.9%64.7%65.6%66.6%65.5%
Operating margin16.5%20.1%15.9%20.6%12.8%17.3%15.3%14.8%18.1%16.7%
Net margin13.9%17.4%5.5%17.6%9.8%100.8%11.7%8.2%10.1%9.2%

Balance sheet

fiscal years · USD
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash & equivalents$100.80M$88.80M$77.70M$89.00M$115.90M$95.90M$138.20M$120.80M$107.60M$110.60M
Receivables$291.40M$316.60M$374.70M$435.30M$435.40M$515.30M$557.80M$609.70M$717.00M$829.00M
Inventory$417.70M$454.10M$468.80M$506.90M$570.40M$585.60M$628.70M$735.60M$802.70M$846.00M
Total current assets$937.10M$953.20M$1.09B$1.16B$1.27B$1.47B$1.53B$1.70B$1.95B$2.11B
Goodwill$2.16B$2.35B$2.39B$2.43B$2.45B$2.57B$3.61B$3.62B$3.84B$3.85B
Total assets$4.48B$4.86B$6.11B$6.27B$6.74B$9.61B$11.49B$11.66B$12.32B$12.39B
Total current liabilities$543.20M$396.10M$536.50M$1.11B$1.00B$732.10M$1.28B$969.00M$1.02B$1.11B
Short-term debt$210.70M$0$37.10M$563.70M$409.30M$83.40M$412.60M$45.40M$33.30M$47.80M
Long-term debt$1.11B$1.15B$1.99B$1.26B$1.38B$1.40B$2.35B$2.52B$2.55B$2.46B
Total debt$1.32B$1.15B$2.02B$1.83B$1.79B$1.48B$2.76B$2.57B$2.58B$2.50B
Total liabilities$1.78B$1.68B$2.81B$2.65B$2.91B$2.66B$4.32B$4.11B$4.23B$4.16B
Shareholders' equity$2.70B$3.18B$3.31B$3.63B$3.82B$6.94B$7.17B$7.55B$8.08B$8.24B

Cash flow

fiscal years · USD
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow$509.60M$593.60M$668.90M$713.20M$486.60M$738.60M$692.40M$607.50M$709.30M$796.10M
Capital expenditures$152.60M$127.20M$193.60M$292.10M$310.40M$214.40M$242.00M$392.50M$421.20M$362.40M
Free cash flow$357.00M$466.40M$475.30M$421.10M$176.20M$524.20M$450.40M$215.00M$288.10M$433.70M
Investing cash flow-$418.70M-$381.30M-$1.52B-$351.30M-$364.50M-$450.30M-$1.83B-$449.00M-$764.60M-$372.90M
Financing cash flow-$1.40M-$227.90M$844.40M-$351.40M-$95.50M-$311.40M$1.19B-$173.90M$39.20M-$425.90M
Dividends paid$2.90M$2.90M$2.90M$3.00M$3.00M$3.00M$3.00M$3.00M$0$0
Share buybacks$0$55.00M$0$156.10M$47.80M$24.80M$78.50M$0$0$290.10M
Stock-based compensation$29.90M$37.20M$43.20M$35.10M$37.60M$43.80M$54.20M$62.10M$75.10M$70.50M
Depreciation & amortization$198.30M$188.40M$275.10M$280.80M$149.90M$309.30M$346.10M$367.70M$375.10M$377.40M

Quarterly figures are rebuilt from the year-to-date totals companies report — Q4 is the full year minus the first nine months, since no 10-Q is filed for it. Values are as filed; later restatements replace earlier ones. Fiscal years are labelled by the calendar year in which they end.